Find the latest pharmaceutical market place for formulations enquiry about Epoprostenol Sodium on PharmaCompass.com.

Epoprostenol Powder for Injections needed in Canada [ENA15703]

An independent consultant based in the Netherlands having 20+ years of experience in the pharmaceutical industry is looking for suppliers of Epoprostenol Powder for Injections for commercial purposes. The required packaging is in vials. The suppliers must support this enquiry with dossier and FDA/ EUGMP.
1. Epoprostenol (0.5 mg) Powder for Injections. The required quantity is 1,149 units for first year, 1,578 units for second year, 2,011 units for third year, 2,032 units for fourth year & 2,052 units for fifth year.
2. Epoprostenol (1.5 mg) Powder for Injections. The required quantity is 30,251 units for first year, 41,545 units for second year, 52,970 units for third year, 53,500 units for fourth year & 54,035 units for fifth year.

Reply

01 Dec 2022

Tender// Various Finished Dosage Formulations needed in Poland [ENA10510]

Upper Silesian Medical Center prof. Leszek Giec of the Medical University of Silesia in Katowice is looking for supplies of Various Finished Dosage Formulations. The suppliers must support this tender with ESPD. The deadline is 8-June-2021.
1. Infliximab (100 mg) Injections. The required quantity is 400 units.
2. Interferon Beta-1A (44 mcg/ 0.5 ml x 4 cartridges and 1.5 ml) Cartridge. The required quantity is 240 units.
3. Macitentan (10 mg) Tablets. The required quantity is 380 units.
4. Epoprostenol (0.5 mg and 1.5 mg) Solution for infusion. The required quantity is 30 units and 3,000 units respectively.
5. Interferon Beta-1A (30 mcg/ 0.5 ml) Powder + solvent. The required quantity is 360 units.

Reply

27 May 2021